Download PDF
Am J Perinatol 2017; 34(14): 1382-1388
DOI: 10.1055/s-0037-1604244
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Melatonin and Neonatal Sepsis: A Promising Antioxidant Adjuvant Agent

Gabriella D'Angelo
1   Department of Human Pathology in Adult and Developmental Age, University of Messina, Messina, Italy
,
Lucia Marseglia
1   Department of Human Pathology in Adult and Developmental Age, University of Messina, Messina, Italy
,
Russel J. Reiter
2   Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
,
Giuseppe Buonocore
3   Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
,
Eloisa Gitto
1   Department of Human Pathology in Adult and Developmental Age, University of Messina, Messina, Italy
› Author Affiliations
Further Information

Publication History

28 April 2017

08 June 2017

Publication Date:
13 July 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Sepsis represents a major clinical problem in neonatal setting with elevated mortality rate related to multiple organ failure. Despite decades of research, the exact mechanism of organ failure in sepsis is still not completely understood. Oxidative stress (OS), derived from an imbalance between pro-oxidant and antioxidant factors, is involved in the pathogenesis of several neonatal diseases, including sepsis, and plays a particular role in systemic organ failure. Recently, it has been recognized that administration of antioxidants could be useful in septic patients. Among all antioxidants, melatonin has a characteristic role as an antioxidant, anti-inflammatory, and anti-apoptotic agent. In combination with other interventions, melatonin may contribute to an improvement in septic organ injury. Furthermore, melatonin has already been widely used in treating various diseases of neonatal population, including asphyxia, respiratory distress, and sepsis, and no significant toxicity or treatment-related side effects with long-term melatonin therapy have been reported. This review aims to summarize current knowledge concerning the potential beneficial role of melatonin in septic neonates, supporting its short-term adjuvant co-therapy to reduce complications during neonatal sepsis.

Keywords

melatonin - sepsis - newborn - oxidative stress - antioxidant

Note

As a review article, no research ethics application is required.


Funding

None.


 

  • References

  • 1 Perez EM, Weisman LE. Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol 1997; 24 (01) 213-229
    CrossrefPubMedGoogle Scholar
  • 2 Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988; 23 (02) 143-150
    CrossrefPubMedGoogle Scholar
  • 3 Haynes RL, Folkerth RD, Keefe RJ. , et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003; 62 (05) 441-450
    CrossrefPubMedGoogle Scholar
  • 4 Clyman RI, Saugstad OD, Mauray F. Reactive oxygen metabolites relax the lamb ductus arteriosus by stimulating prostaglandin production. Circ Res 1989; 64 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 5 Bentlin MR, de Souza Rugolo LMS. Late-onset sepsis: epidemiology, evaluation, and outcome. Neoreviews 2010; 11 (08) e426-e435
    CrossrefPubMedGoogle Scholar
  • 6 Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 2000; 7 (02) 83-101
    CrossrefPubMedGoogle Scholar
  • 7 Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007; 35 (10) 2408-2416
    CrossrefPubMedGoogle Scholar
  • 8 Wendel M, Heller AR. Mitochondrial function and dysfunction in sepsis. Wien Med Wochenschr 2010; 160 (5-6): 118-123
    CrossrefPubMedGoogle Scholar
  • 9 Galley HF. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010; 14 (04) 230
    CrossrefPubMedGoogle Scholar
  • 10 Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44 (04) 175-200
    Google Scholar
  • 11 Marseglia L, Aversa S, Barberi I. , et al. High endogenous melatonin levels in critically ill children: a pilot study. J Pediatr 2013; 162 (02) 357-360
    CrossrefPubMedGoogle Scholar
  • 12 Gitto E, Marseglia L, Manti S. , et al. Protective role of melatonin in neonatal diseases. Oxid Med Cell Longev 2013; 2013: 980374
    PubMedGoogle Scholar
  • 13 Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54 (03) 245-257
    CrossrefPubMedGoogle Scholar
  • 14 Venegas C, García JA, Escames G. , et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52 (02) 217-227
    CrossrefPubMedGoogle Scholar
  • 15 Víctor VM, Espulgues JV, Hernández-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets 2009; 9 (04) 376-389
    CrossrefPubMedGoogle Scholar
  • 16 Gitto E, Aversa S, Reiter RJ, Barberi I, Pellegrino S. Update on the use of melatonin in pediatrics. J Pineal Res 2011; 50 (01) 21-28
    CrossrefPubMedGoogle Scholar
  • 17 Bersani I, Auriti C, Ronchetti MP, Prencipe G, Gazzolo D, Dotta A. Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives. BioMed Res Int 2015; 2015: 253520
    PubMedGoogle Scholar
  • 18 Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 2004; 4 (5-6): 729-741
    CrossrefPubMedGoogle Scholar
  • 19 Rinaldi S, Landucci F, De Gaudio AR. Antioxidant therapy in critically septic patients. Curr Drug Targets 2009; 10 (09) 872-880
    CrossrefPubMedGoogle Scholar
  • 20 Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006; 91 (03) F208-F212
    PubMedGoogle Scholar
  • 21 Berner R, Tüxen B, Clad A, Forster J, Brandis M. Elevated gene expression of interleukin-8 in cord blood is a sensitive marker for neonatal infection. Eur J Pediatr 2000; 159 (03) 205-210
    CrossrefPubMedGoogle Scholar
  • 22 Schultz C, Temming P, Bucsky P, Göpel W, Strunk T, Härtel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004; 135 (01) 130-136
    CrossrefPubMedGoogle Scholar
  • 23 Lowes DA, Webster NR, Murphy MP, Galley HF. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth 2013; 110 (03) 472-480
    CrossrefPubMedGoogle Scholar
  • 24 Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011; 107 (01) 57-64
    CrossrefPubMedGoogle Scholar
  • 25 Hirsiger S, Simmen HP, Werner CM, Wanner GA, Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm 2012; 2012: 315941
    PubMedGoogle Scholar
  • 26 Prauchner CA. Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy. Burns 2017; 43 (03) 471-485
    CrossrefPubMedGoogle Scholar
  • 27 von Dessauer B, Bongain J, Molina V, Quilodrán J, Castillo R, Rodrigo R. Oxidative stress as a novel target in pediatric sepsis management. J Crit Care 2011; 26 (01) 103.e1-103.e7
    PubMedGoogle Scholar
  • 28 Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30 (08) 1782-1786
    CrossrefPubMedGoogle Scholar
  • 29 Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23 (04) 646-651
    CrossrefPubMedGoogle Scholar
  • 30 Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in human with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76 (04) 1539-1553
    CrossrefPubMedGoogle Scholar
  • 31 Parratt JR. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 1998; 41 (Suppl A ): 31-39
    CrossrefPubMedGoogle Scholar
  • 32 Kumar A, Brar R, Wang P. , et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999; 276 (1 Pt 2): R265-R276
    PubMedGoogle Scholar
  • 33 Brealey D, Brand M, Hargreaves I. , et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360 (9328): 219-223
    CrossrefPubMedGoogle Scholar
  • 34 Brown GC, Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 2007; 75 (02) 283-290
    CrossrefPubMedGoogle Scholar
  • 35 Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta 2015; 451 (Pt 0A): 46-64
    CrossrefPubMedGoogle Scholar
  • 36 Sakr Y, Reinhart K, Bloos F. , et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 2007; 98 (06) 775-784
    CrossrefPubMedGoogle Scholar
  • 37 Borrelli E, Roux-Lombard P, Grau GE. , et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24 (03) 392-397
    CrossrefPubMedGoogle Scholar
  • 38 Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care 2012; 16 (02) R66
    CrossrefPubMedGoogle Scholar
  • 39 Lerner AB, Case JD, Takahashi Y. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958; 80: 2587-2592
    PubMedGoogle Scholar
  • 40 Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181: 127-151
    Google Scholar
  • 41 Gitto E, Pellegrino S, Gitto P, Barberi I, Reiter RJ. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009; 46 (02) 128-139
    CrossrefPubMedGoogle Scholar
  • 42 Jan JE, Reiter RJ, Wasdell MB, Bax M. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009; 46 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 43 Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol 2008; 4 (08) 436-447
    PubMedGoogle Scholar
  • 44 Dauchy RT, Blask DE, Dauchy EM. , et al. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts. J Pineal Res 2009; 47 (01) 32-42
    CrossrefPubMedGoogle Scholar
  • 45 Gitto E, Marseglia L, D'Angelo G. , et al. Melatonin versus midazolam premedication in children undergoing surgery: A pilot study. J Paediatr Child Health 2016; 52 (03) 291-295
    CrossrefPubMedGoogle Scholar
  • 46 Gitto E, Karbownik M, Reiter RJ. , et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50 (06) 756-760
    CrossrefPubMedGoogle Scholar
  • 47 Marseglia L, Cuppari C, Manti S. , et al. Atopic dermatitis: melatonin as potential treatment. J Biol Regul Homeost Agents 2015; 29 (2, Suppl 1) 142-149
    PubMedGoogle Scholar
  • 48 Li Volti G, Musumeci T, Pignatello R. , et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med (Maywood) 2012; 237 (06) 670-677
    CrossrefPubMedGoogle Scholar
  • 49 Shang Y, Xu SP, Wu Y. , et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J (Engl) 2009; 122 (12) 1388-1393
    PubMedGoogle Scholar
  • 50 Wu JY, Tsou MY, Chen TH, Chen SJ, Tsao CM, Wu CC. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. J Pineal Res 2008; 45 (01) 106-116
    CrossrefPubMedGoogle Scholar
  • 51 Escames G, Acuña-Castroviejo D, López LC. , et al. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006; 58 (09) 1153-1165
    CrossrefPubMedGoogle Scholar
  • 52 Wu CC, Chiao CW, Hsiao G, Chen A, Yen MH. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res 2001; 30 (03) 147-156
    CrossrefPubMedGoogle Scholar
  • 53 Carrillo-Vico A, Lardone PJ, Naji L. , et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005; 39 (04) 400-408
    CrossrefPubMedGoogle Scholar
  • 54 García JA, Ortiz F, Miana J. , et al. Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice. J Physiol Biochem 2017; 73 (02) 235-244
    CrossrefPubMedGoogle Scholar
  • 55 Sener G, Toklu H, Kapucu C. , et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 2005; 35 (01) 52-59
    PubMedGoogle Scholar
  • 56 Ortiz F, García JA, Acuña-Castroviejo D. , et al. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res 2014; 56 (01) 71-81
    CrossrefPubMedGoogle Scholar
  • 57 Fink T, Glas M, Wolf A. , et al. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Crit Care Med 2014; 42 (01) e22-e31
    CrossrefPubMedGoogle Scholar
  • 58 Doerrier C, García JA, Volt H. , et al. Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network. Mitochondrion 2016; 27: 56-63
    CrossrefPubMedGoogle Scholar
  • 59 Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H, Cardinali DP. Melatonin in septic shock: some recent concepts. J Crit Care 2010; 25 (04) 656.e1-656.e6
    PubMedGoogle Scholar
  • 60 Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51 (01) 1-16
    CrossrefPubMedGoogle Scholar
  • 61 Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 2013; 13 (03) 373-384
    PubMedGoogle Scholar
  • 62 Galley HF, Lowes DA, Allen L, Cameron G, Aucott LS, Webster NR. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 2014; 56 (04) 427-438
    CrossrefPubMedGoogle Scholar
  • 63 Batra S, Kumar R, Kapoor AK, Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 2000; 20 (01) 27-33
    CrossrefPubMedGoogle Scholar
  • 64 Seema KR, Kumar R, Mandal RN. , et al. Serum TNF-alpha and free radical scavengers in neonatal septicemia. Indian J Pediatr 1999; 66 (04) 511-516
    CrossrefPubMedGoogle Scholar
  • 65 Cancelier AC, Petronilho F, Reinke A. , et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatr Crit Care Med 2009; 10 (04) 467-471
    CrossrefPubMedGoogle Scholar
  • 66 Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000; 7 (06) 444-458
    Google Scholar
  • 67 Rodriguez C, Mayo JC, Sainz RM. , et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 68 El Frargy M, El-Sharkawy HM, Attia GF. Use of melatonin as an adjuvant therapy in neonatal sepsis. J Neonatal Perinatal Med 2015; 8 (03) 227-232
    PubMedGoogle Scholar
  • 69 El-Mashad AR, Elmahdy H, El-Dib M, Elbatch M, Aly H. Can melatonin be used as a marker for neonatal sepsis?. J Matern Fetal Neonatal Med 2016; 29 (17) 2870-2873
    PubMedGoogle Scholar
  • 70 Lowes DA, Almawash AM, Webster NR, Reid VL, Galley HF. Melatonin and structurally similar compounds have differing effects on inflammation and mitochondrial function in endothelial cells under conditions mimicking sepsis. Br J Anaesth 2011; 107 (02) 193-201
    CrossrefPubMedGoogle Scholar
  • 71 López A, García JA, Escames G. , et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009; 46 (02) 188-198
    CrossrefPubMedGoogle Scholar
  • 72 Volt H, García JA, Doerrier C. , et al. Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin. J Pineal Res 2016; 60 (02) 193-205
    CrossrefPubMedGoogle Scholar
  • 73 Ortiz F, Acuña-Castroviejo D, Doerrier C. , et al. Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res 2015; 58 (01) 34-49
    CrossrefPubMedGoogle Scholar
  • 74 Lorente L, Martín MM, Abreu-González P. , et al. Serum melatonin levels are associated with mortality in severe septic patients. J Crit Care 2015; 30 (04) 860.e1-860.e6
    CrossrefPubMedGoogle Scholar
  • 75 Bagci S, Horoz ÖÖ, Yildizdas D, Reinsberg J, Bartmann P, Müller A. Melatonin status in pediatric intensive care patients with sepsis. Pediatr Crit Care Med 2012; 13 (02) e120-e123
    CrossrefPubMedGoogle Scholar
  • 76 Gitto E, Reiter RJ, Karbownik M. , et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate 2002; 81 (03) 146-157
    CrossrefPubMedGoogle Scholar
  • 77 Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996; 85 (01) 1-4
    PubMedGoogle Scholar
  • 78 Shim H, Jang JY, Lee SH, Lee JG. Correlation of the oxygen radical activity and antioxidants and severity in critically ill surgical patients – study protocol. World J Emerg Surg 2013; 8 (01) 18
    CrossrefPubMedGoogle Scholar
  • 79 Huet O, Dupic L, Harrois A, Duranteau J. Oxidative stress and endothelial dysfunction during sepsis. Front Biosci (Landmark Ed) 2011; 16: 1986-1995
    CrossrefPubMedGoogle Scholar
  • 80 Martín M, Macías M, Escames G. , et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000; 28 (04) 242-248
    CrossrefPubMedGoogle Scholar
  • 81 Fulia F, Gitto E, Cuzzocrea S. , et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31 (04) 343-349
    Google Scholar
  • 82 Gitto E, Reiter RJ, Cordaro SP. , et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004; 21 (04) 209-216
    Google Scholar
  • 83 Gitto E, Reiter RJ, Amodio A. , et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004; 36 (04) 250-255
    Google Scholar
  • 84 Gitto E, Romeo C, Reiter RJ. , et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004; 39 (02) 184-189
    CrossrefPubMedGoogle Scholar
  • 85 Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50 (02) 271-279
    CrossrefPubMedGoogle Scholar
  • 86 Sánchez-Barceló EJ, Mediavilla MD, Tan DX, Reiter RJ. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17 (19) 2070-2095
    CrossrefPubMedGoogle Scholar
  • 87 Hu W, Deng C, Ma Z. , et al. Utilizing melatonin to combat bacterial infections and septic injury. Br J Pharmacol 2017; 174 (09) 754-768
    CrossrefPubMedGoogle Scholar